Yao-Kuang Wang

Yao-Kuang Wang

Auto-generated profile, based on publicly available information

Yao-Kuang Wang

Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung Taiwan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
JWJiunn-Wei Wang
Jiunn-Wei Wang
CKChao-Hung Kuo
Chao-Hung Kuo
FKFu-Chen Kuo
Fu-Chen Kuo
YWYao-Kuang Wang
Yao-Kuang Wang
WHWen-Hung Hsu
Wen-Hung Hsu
DWDeng-Chyang Wu
Deng-Chyang Wu
Fecal microbiota transplantation (FMT) is a method to directly change the recipient's gut microbiota to normalize the composition and gain a therapeutic benefit. The history of FMT has been traced back to the 4th century and has been highly regarded since 2013, when the United States Food and Drug Administration approved FMT for treating recurrent and refractory Clostridium difficile infection. Since then, the range of FMT applications extended rapidly and broadly not only in gastrointestinal disorders, but also in extra-gastrointestinal diseases. Donor selection with questionnaire, interview, blood tests, and stool examinations should be strictly performed before FMT to reduce and prevent occurrence of any adverse events. Step-by-step cautious fecal and recipient preparation along with adequately choosing delivery methods based on individual clinical situations are key points of the FMT process. Although current evidence deems FMT as a generally safe therapeutic method with few adverse effects, the long-term outcomes of FMT have not been completely elucidated. Therefore, establishing periodicity and length of regular follow-up after FMT to monitor the clinical efficacy and long-term adverse events are other essential issues. In the future, we will look forward to personalized FMT for different patients and conditions according to varied hosts and diseases.

1 January 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
YWYao-Kuang Wang
Yao-Kuang Wang
FKFu-Chen Kuo
Fu-Chen Kuo
CLChung-Jung Liu
Chung-Jung Liu
MWMeng-Chieh Wu
Meng-Chieh Wu
HSHsiang-Yao Shih
Hsiang-Yao Shih
DWDeng-Chyang Wu
Deng-Chyang Wu
Accurate diagnosis of Helicobacter pylori (H. pylori) infection is a crucial part in the effective management of many gastroduodenal diseases. Several invasive and non-invasive diagnostic tests are available for the detection of H. pylori and each test has its usefulness and limitations in different clinical situations. Although none can be considered as a single gold standard in clinical practice, several techniques have been developed to give the more reliable results. Invasive tests are performed via endoscopic biopsy specimens and these tests include histology, culture, rapid urease test as well as molecular methods. Developments of endoscopic equipment also contribute to the real-time diagnosis of H. pylori during endoscopy. Urea breathing test and stool antigen test are most widely used non-invasive tests, whereas serology is useful in screening and epidemiological studies. Molecular methods have been used in variable specimens other than gastric mucosa. More than detection of H. pylori infection, several tests are introduced into the evaluation of virulence factors and antibiotic sensitivity of H. pylori, as well as screening precancerous lesions and gastric cancer. The aim of this article is to review the current options and novel developments of diagnostic tests and their applications in different clinical conditions or for specific purposes.

13 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CTCho-Lun Tsai
Cho-Lun Tsai
Arvind MukundanArvind Mukundan
Arvind Mukundan
CCChen-Shuan Chung
Chen-Shuan Chung
Yi-Hsun ChenYi-Hsun Chen
Yi-Hsun Chen
YWYao-Kuang Wang
Yao-Kuang Wang
Hsiang-Chen WangHsiang-Chen Wang
Hsiang-Chen Wang
This study uses hyperspectral imaging (HSI) and a deep learning diagnosis model that can identify the stage of esophageal cancer and mark the locations. This model simulates the spectrum data from the image using an algorithm developed in this study which is combined with deep learning for the classification and diagnosis of esophageal cancer using a single-shot multibox detector (SSD)-based identification system. Some 155 white-light endoscopic images and 153 narrow-band endoscopic images of esophageal cancer were used to evaluate the prediction model. The algorithm took 19 s to predict the results of 308 test images and the accuracy of the test results of the WLI and NBI esophageal cancer was 88 and 91%, respectively, when using the spectral data. Compared with RGB images, the accuracy of the WLI was 83% and the NBI was 86%. In this study, the accuracy of the WLI and NBI was increased by 5%, confirming that the prediction accuracy of the HSI detection method is significantly improved.

1 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
TTTsung-Jung Tsai
Tsung-Jung Tsai
Arvind MukundanArvind Mukundan
Arvind Mukundan
YCYu-Sheng Chi
Yu-Sheng Chi
TYTsao Yu-Ming
Tsao Yu-Ming
YWYao-Kuang Wang
Yao-Kuang Wang
Hsiang-Chen WangHsiang-Chen Wang
Hsiang-Chen Wang
In this study, the combination of hyperspectral imaging (HSI) technology and band selection was coupled with color reproduction. The white-light images (WLIs) were simulated as narrow-band endoscopic images (NBIs). As a result, the blood vessel features in the endoscopic image became more noticeable, and the prediction performance was improved. In addition, a single-shot multi-box detector model for predicting the stage and location of esophageal cancer was developed to evaluate the results. A total of 1780 esophageal cancer images, including 845 WLIs and 935 NBIs, were used in this study. The images were divided into three stages based on the pathological features of esophageal cancer: normal, dysplasia, and squamous cell carcinoma. The results showed that the mean average precision (mAP) reached 80% in WLIs, 85% in NBIs, and 84% in HSI images. This study′s results showed that HSI has more spectral features than white-light imagery, and it improves accuracy by about 5% and matches the results of NBI predictions.

30 July 2017 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
YWYao‐Kuang Wang
Yao‐Kuang Wang
YCYun-Shiuan Chuang
Yun-Shiuan Chuang
TWTzung‐Shiun Wu
Tzung‐Shiun Wu
KLKa‐Wo Lee
Ka‐Wo Lee
CWChe-Wei Wu
Che-Wei Wu
IWI-Chen Wu
I-Chen Wu
Esophageal squamous‐cell neoplasia (ESCN) is a common second primary neoplasia found in patients with head‐and‐neck squamous‐cell carcinoma (HNSCC). This study sought to identify the risk factors for synchronous ESCN and how they influence survival in HNSCC patient. Eight hundred and fifteen incident HNSCC patients were prospectively recruited for endoscopy screening for ESCN using white‐light imaging, narrow‐band imaging, Lugol chromoendoscopy, and pathological confirmation. Associated lifestyle and clinicopathological data were collected. The interquartile follow‐up period cutoffs were 11.3, 20.5 and 34.9 months. 124 patients (15.2%) were diagnosed as having synchronous ESCN (66 low‐grade dysplasia, 29 high‐grade dysplasia, and 29 esophageal squamous‐cell carcinoma). Consumption of alcohol, but not betel nut or cigarette, was significantly associated with the presence of synchronous ESCN (adjusted odds ratio [aOR] = 7.1 and 10.9 for former and current drinkers, respectively). There was an interaction between cumulative dose of alcohol consumption and alcohol flushing response on the development of ESCN. High‐dose drinkers with flush response were 16.9 times more likely to have esophageal high‐grade dysplasia/SCC than non‐drinkers. Compared with oral cavity cancer patients, those with hypopharyngeal, laryngeal and oropharyngeal cancer were 6.8, 4.6 and 2.8 times more likely to have esophageal high‐grade dysplasia/SCC. HNSCC patients with synchronous ESCN had lower overall survival than those without (p < 0.0001). In conclusion, surveillance of ESCN is strongly recommended for the high‐risk subpopulation of HNSCC patients, especially drinkers who have a flush response to alcohol, and those with distant metastasis of index cancer and cancers in hypopharynx, oropharynx and larynx.

17 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
YWYao-Kuang Wang
Yao-Kuang Wang
HSHao-Yi Syu
Hao-Yi Syu
Yi-Hsun ChenYi-Hsun Chen
Yi-Hsun Chen
CCChen-Shuan Chung
Chen-Shuan Chung
YTYu Sheng Tseng
Yu Sheng Tseng
Hsiang-Chen WangHsiang-Chen Wang
Hsiang-Chen Wang
Diagnosis of early esophageal neoplasia, including dysplasia and superficial cancer, is a great challenge for endoscopists. Recently, the application of artificial intelligence (AI) using deep learning in the endoscopic field has made significant advancements in diagnosing gastrointestinal cancers. In the present study, we constructed a single-shot multibox detector using a convolutional neural network for diagnosing different histological grades of esophageal neoplasms and evaluated the diagnostic accuracy of this computer-aided system. A total of 936 endoscopic images were used as training images, and these images included 498 white-light imaging (WLI) and 438 narrow-band imaging (NBI) images. The esophageal neoplasms were divided into three classifications: squamous low-grade dysplasia, squamous high-grade dysplasia, and squamous cell carcinoma, based on pathological diagnosis. This AI system analyzed 264 test images in 10 s, and the sensitivity, specificity, and diagnostic accuracy of this system in detecting esophageal neoplasms were 96.2%, 70.4%, and 90.9%, respectively. The accuracy of this AI system in differentiating the histological grade of esophageal neoplasms was 92%. Our system showed better accuracy in diagnosing NBI (95%) than WLI (89%) images. Our results showed the great potential of AI systems in identifying esophageal neoplasms as well as differentiating histological grades.